{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05906953",
            "orgStudyIdInfo": {
                "id": "HG00402"
            },
            "organization": {
                "fullName": "HuidaGene Therapeutics Co., Ltd.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Safety and Efficacy Trial of HG004 for Leber Congenital Amaurosis Related to Rpe65 Gene Mutations (STAR)",
            "officialTitle": "A Phase 1/2, Open-label, Multi-national, Multiple-cohort, Dose-escalation Study to Evaluate the Safety, Tolerability, and Efficacy of HG004 Gene Therapy in Subjects With RPE65-associated Leber Congenital Amaurosis Type 2 (LCA2)",
            "therapeuticArea": [
                "Ophthalmology",
                "Other"
            ],
            "study": "safety-and-efficacy-trial-of-for-leber-congenital-amaurosis-related-to-gene-mutations-star"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-11",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-10-31",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-05-09",
            "studyFirstSubmitQcDate": "2023-06-13",
            "studyFirstPostDateStruct": {
                "date": "2023-06-18",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-11-09",
            "lastUpdatePostDateStruct": {
                "date": "2023-11-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "HuidaGene Therapeutics Co., Ltd.",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Cholgene Therapeutics, Inc.",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of the study is to determine whether HG004 as gene therapy is safe and effective for the treatment of Leber Congenital Amaurosis caused by mutations in RPE65 gene."
        },
        "conditionsModule": {
            "conditions": [
                "Leber Congenital Amaurosis",
                "Inherited Retinal Diseases Caused by RPE65 Mutations"
            ],
            "keywords": [
                "IRD",
                "LCA",
                "LCA2"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "HG004",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: HG004"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "HG004",
                    "description": "Low dose Medium dose High dose",
                    "armGroupLabels": [
                        "HG004"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of ocular and non-ocular adverse events",
                    "timeFrame": "52 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change from baseline in Best Corrected Visual Acuity (BCVA) of letters based on the Early Treatment Diabetic Retionpathy Study (ETDRS) chart",
                    "timeFrame": "52 weeks"
                },
                {
                    "measure": "Change from baseline in visual fields of full-field stimulus threshold test in log cd.s/m2.",
                    "timeFrame": "52 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or females between 6 and 50 years of age at the time of signing the informed consent form.\n* Willing to adhere to protocol as evidenced by written informed consent or parental permission and subject assent.\n* Clinical confirmed diagnosis of Leber congenital amaurosis (LCA) and molecular diagnosis of LCA due to RPE65 mutations.\n* Ability to perform tests of visual and retinal function.\n* Visual acuity of \u2264 20/80 or visual field less than 20 degrees in the eye to be injected.\n* Acceptable hematology, clinical chemistry, and urine laboratory parameters.\n\nExclusion Criteria:\n\n* Pre-existing eye conditions that would preclude the planned surgery or interfere with interpretation of study endpoints or complications of surgery (e.g., glaucoma requiring upcoming surgery, corneal or significant lenticular opacities).\n* Presence of epiretinal membrane by OCT.\n* Complicating systemic diseases or clinically significant abnormal baseline laboratory values.\n* Complicating systemic diseases would include those in which the disease itself, or the treatment for the disease, can alter ocular function.\n* Prior ocular surgery within six months.\n* Prior gene therapy or oligonucleotide therapy treatments.\n* Any condition which leads the investigator to believe that the participant cannot comply with the protocol requirements or that may place the participant at an unacceptable risk for participation.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "6 Years",
            "maximumAge": "50 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Study Director",
                    "role": "CONTACT",
                    "phone": "+862125076143",
                    "email": "HG00402@huidagene.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Study Director",
                    "affiliation": "HuidaGene Therapeutics Co., Ltd.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Research Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Sacramento",
                    "state": "California",
                    "zip": "95817",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Director",
                            "role": "CONTACT",
                            "email": "HG00402@huidagene.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.58157,
                        "lon": -121.4944
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77707",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Director",
                            "role": "CONTACT",
                            "email": "HG00402@huidagene.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Shanghai",
                    "state": "Shanghai",
                    "country": "China",
                    "contacts": [
                        {
                            "name": "Study Director",
                            "role": "CONTACT",
                            "email": "HG00402@huidagene.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001766",
                    "term": "Blindness"
                },
                {
                    "id": "D000012164",
                    "term": "Retinal Diseases"
                },
                {
                    "id": "D000057130",
                    "term": "Leber Congenital Amaurosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                },
                {
                    "id": "D000014786",
                    "term": "Vision Disorders"
                },
                {
                    "id": "D000012678",
                    "term": "Sensation Disorders"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000015785",
                    "term": "Eye Diseases, Hereditary"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14999",
                    "name": "Retinal Diseases",
                    "asFound": "Retinal Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M28730",
                    "name": "Leber Congenital Amaurosis",
                    "asFound": "Leber Congenital Amaurosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5047",
                    "name": "Blindness",
                    "asFound": "Amaurosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17530",
                    "name": "Vision Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M15490",
                    "name": "Sensation Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M18339",
                    "name": "Eye Diseases, Hereditary",
                    "relevance": "LOW"
                },
                {
                    "id": "T3335",
                    "name": "Leber Congenital Amaurosis",
                    "asFound": "Leber Congenital Amaurosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3344",
                    "name": "Leber Congenital Amaurosis 2",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}